Skip to main navigation
Skip to search
Skip to main content
Princeton University Home
Help & FAQ
Home
Profiles
Research units
Facilities
Projects
Research output
Press/Media
Search by expertise, name or affiliation
Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
Andrew E. Hogan
, Gadintshware Gaoatswe
,
Lydia Lynch
, Michelle A. Corrigan
, Conor Woods
, Jean O'Connell
, Donal O'Shea
Research output
:
Contribution to journal
›
Article
›
peer-review
208
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glucagon-like
100%
Immune-mediated Inflammation
100%
Soluble CD163
30%
Changes in Body Weight
10%
Type 2 Diabetes Mellitus Patients
10%
Gut Hormones
10%
Fructosamine
10%
Pro-inflammatory Adipokines
10%
Macrophage Polarization
10%
Diabetes Services
10%
Obese Type 2 Diabetes Mellitus
10%
Medicine and Dentistry
Glucagon Like Peptide 1
100%
Adipocytokine
20%
Macrophage Polarization
10%
Gastrointestinal Hormone
10%
Fructosamine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon-Like Peptide-1
100%
Adipocytokine
20%
Fructosamine
10%
Gastrointestinal Hormone
10%
Immunology and Microbiology
CD163
100%